Skip to content
Screener

Ashland ASH Life Sciences — Selling General And Administrative Expense

Other segment segments

Unallocated And Other
$38M-22.4%
Personal Care And Household
$22M+4.8%
Specialty Additives
$17M0.0%
Intermediates And Solvents
$2M+100%

Similar metrics at other companies

Ecolab logo
ECLGlobal Life Sciences — Selling General And Administrative Expense
$55.2M+8.0%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Selling General And Administrative Expense
$1.2M-16.0%
TEC
TECHProtein Sciences — Selling General And Administrative Expense
$57.91M+3.8%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%
Armstrong World Industries logo
AWIMineral Fiber — Selling General And Administrative Expense
$48.7M+10.7%
Flexible Solutions International logo
FSISelling General And Administrative Expense
$762.36K+0.8%

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)Three months ended / June 30 / 2026Three months ended / June 30 / 2025Nine months ended / June 30 / 2026Nine months ended / June 30 / 2025
Intersegment sales(11)(10)(29)(31)
$327$331$943$957
Selling, general and administrative expense
Life Sciences$20$18$61$58
Personal Care22216362
Specialty Additives17175049
Intermediates2164
Total operating segments6157180173

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's life sciences — selling general and administrative expense?
Ashland (ASH) reported life sciences — selling general and administrative expense of $20M in Q2 2026.
How has Ashland's life sciences — selling general and administrative expense changed year-over-year?
Ashland's life sciences — selling general and administrative expense increased by 11.1% year-over-year, from $18M to $20M.
What is the long-term trend for Ashland's life sciences — selling general and administrative expense?
Over 2 years (2023 to 2025), Ashland's life sciences — selling general and administrative expense has grown at a -7.6% compound annual growth rate (CAGR), from $89M to $76M.
What does life sciences — selling general and administrative expense mean?
This metric encompasses the indirect costs of operating the segment, including sales, marketing, legal, and administrative support functions. It reflects the overhead required to maintain and grow the business outside of direct production costs. Efficient management of these expenses is essential for maintaining operating margins and overall segment profitability.

Ask your AI about Ashland's life sciences — selling general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude